196 related articles for article (PubMed ID: 12878534)
1. Reduced release of pneumolysin by Streptococcus pneumoniae in vitro and in vivo after treatment with nonbacteriolytic antibiotics in comparison to ceftriaxone.
Spreer A; Kerstan H; Böttcher T; Gerber J; Siemer A; Zysk G; Mitchell TJ; Eiffert H; Nau R
Antimicrob Agents Chemother; 2003 Aug; 47(8):2649-54. PubMed ID: 12878534
[TBL] [Abstract][Full Text] [Related]
2. Clindamycin is neuroprotective in experimental Streptococcus pneumoniae meningitis compared with ceftriaxone.
Böttcher T; Ren H; Goiny M; Gerber J; Lykkesfeldt J; Kuhnt U; Lotz M; Bunkowski S; Werner C; Schau I; Spreer A; Christen S; Nau R
J Neurochem; 2004 Dec; 91(6):1450-60. PubMed ID: 15584921
[TBL] [Abstract][Full Text] [Related]
3. Experimental study of LY333328 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitis.
Cabellos C; Fernàndez A; Maiques JM; Tubau F; Ardanuy C; Viladrich PF; Liñares J; Gudiol F
Antimicrob Agents Chemother; 2003 Jun; 47(6):1907-11. PubMed ID: 12760866
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide concentrations and cerebrospinal fluid parameters in an experimental animal model of Streptococcus pneumoniae meningitis.
Destache CJ; Pakiz CB; Dash AK; Larsen C
Pharmacotherapy; 1998; 18(3):612-9. PubMed ID: 9620112
[TBL] [Abstract][Full Text] [Related]
5. Experimental study of cerebrospinal fluid tumor necrosis factor-alpha release in penicillin- and cephalosporin-resistant pneumococcal meningitis treated with different antibiotic schedules.
Vivas M; Force E; El Haj C; Tubau F; Ariza J; Cabellos C
J Microbiol Immunol Infect; 2017 Aug; 50(4):435-439. PubMed ID: 26452467
[TBL] [Abstract][Full Text] [Related]
6. Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis.
Olivier C; Cohen R; Begué P; Floret D
Pediatr Infect Dis J; 2000 Oct; 19(10):1015-7. PubMed ID: 11055609
[No Abstract] [Full Text] [Related]
7. Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916.
Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Fernández Viladrich P; Gudiol F
J Antimicrob Chemother; 2005 Nov; 56(5):979-82. PubMed ID: 16174686
[TBL] [Abstract][Full Text] [Related]
8. Quinupristin/dalfopristin attenuates the inflammatory response and reduces the concentration of neuron-specific enolase in the cerebrospinal fluid of rabbits with experimental Streptococcus pneumoniae meningitis.
Trostdorf F; Reinert RR; Schmidt H; Nichterlein T; Stuertz K; Schmitz-Salue M; Sadowski I; Brück W; Nau R
J Antimicrob Chemother; 1999 Jan; 43(1):87-94. PubMed ID: 10381105
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.
Tan TQ; Schutze GE; Mason EO; Kaplan SL
Antimicrob Agents Chemother; 1994 May; 38(5):918-23. PubMed ID: 8067771
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meningitis.
Fitoussi F; Doit C; Benali K; Bonacorsi S; Geslin P; Bingen E
Antimicrob Agents Chemother; 1998 Apr; 42(4):942-4. PubMed ID: 9559815
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro.
Anderson R; Steel HC; Cockeran R; von Gottberg A; de Gouveia L; Klugman KP; Mitchell TJ; Feldman C
J Antimicrob Chemother; 2007 Nov; 60(5):1155-8. PubMed ID: 17848373
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae.
Täuber MG; Doroshow CA; Hackbarth CJ; Rusnak MG; Drake TA; Sande MA
J Infect Dis; 1984 Apr; 149(4):568-74. PubMed ID: 6327835
[TBL] [Abstract][Full Text] [Related]
13. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
[TBL] [Abstract][Full Text] [Related]
14. Influence of subinhibitory concentrations of protein-synthesis-inhibiting antibiotics on production and release of the pneumococcal virulence factor pneumolysin in vitro.
Spreer A; von Ruden C; Mitchell TJ; Eiffert H; Nau R
Chemotherapy; 2007; 53(5):327-31. PubMed ID: 17728540
[TBL] [Abstract][Full Text] [Related]
15. Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci.
Flatz L; Cottagnoud M; Kühn F; Entenza J; Stucki A; Cottagnoud P
J Antimicrob Chemother; 2004 Feb; 53(2):305-10. PubMed ID: 14729741
[TBL] [Abstract][Full Text] [Related]
16. Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis.
Nau R; Zysk G; Schmidt H; Fischer FR; Stringaris AK; Stuertz K; Brück W
J Antimicrob Chemother; 1997 Jun; 39(6):781-8. PubMed ID: 9222048
[TBL] [Abstract][Full Text] [Related]
17. Clindamycin therapy of experimental meningitis caused by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.
París MM; Shelton S; Trujillo M; Hickey SM; McCracken GH
Antimicrob Agents Chemother; 1996 Jan; 40(1):122-6. PubMed ID: 8787892
[TBL] [Abstract][Full Text] [Related]
18. In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.
Stratton CW; Aldridge KE; Gelfand MS
Diagn Microbiol Infect Dis; 1995; 22(1-2):35-42. PubMed ID: 7587048
[TBL] [Abstract][Full Text] [Related]
19. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis.
Klugman KP; Friedland IR; Bradley JS
Antimicrob Agents Chemother; 1995 Sep; 39(9):1988-92. PubMed ID: 8540704
[TBL] [Abstract][Full Text] [Related]
20. Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae.
Anderson R; Steel HC; Cockeran R; Smith AM; von Gottberg A; de Gouveia L; Brink A; Klugman KP; Mitchell TJ; Feldman C
J Antimicrob Chemother; 2007 Feb; 59(2):224-9. PubMed ID: 17218449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
